article thumbnail

Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone

Xconomy

Being first to market with a new type of drug brings advantages. The first mover sets the bar for what physicians, payers, and patients can expect of that medicine and how much it costs. It grabs market share that followers have to steal away. But the first mover isn’t infallible if someone else has something better. is counting on.

Pricing 84
article thumbnail

Bio Roundup: FDA Says No, PCSK9 Value Fight, CRISPR Intrigue & More

Xconomy

All those years of hard work to reach the promised land, then just as a drug owner is ready to spike it home and take a victory lap, the FDA’s hands rise over the net… OK, it’s not a perfect analogy, but it’s better than comparing the patent fight over the gene editing system CRISPR-Cas9 to table tennis. (Be

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Biotech Roundup: Deals Gone Wrong, Ethical Red Flags & Bay Goodbyes

Xconomy

Merck also saw some expected fruits of its 2014 big-ticket acquisition of Cubist Pharmaceuticals wither away this week, as the Supreme Court wouldn’t reverse a decision that shaved years off the patent life of the top-selling antibiotic daptomyicin (Cubicin). The drug has a list price of $69,350 per patient, per year.

article thumbnail

7 Reasons That Investors Won’t Fund Inventions Alone

Startup Professionals Musings

Investors expect proof that your invention can be manufactured in volume, and can justify a sales price at least double the cost, to a large customer set that has money to spend. A long-term advantage usually also requires intellectual property, such as a patent, trade secret, or trademark. Lock in your sustainable advantage.

article thumbnail

7 Business Realities To Temper Invention Excitement

Startup Professionals Musings

Investors expect proof that your invention can be manufactured in volume, and can justify a sales price at least double the cost, to a large customer set that has money to spend. A long-term advantage usually also requires intellectual property, such as a patent, trade secret, or trademark. Lock in your sustainable advantage.

article thumbnail

How Much Should You Get For Your Invention Idea?

Startup Professionals Musings

Investors expect proof that your invention can be manufactured in volume and can justify a sales price at least double the cost to a large customer set that has money to spend. A long-term advantage usually also requires intellectual property, such as a patent, trade secret or trademark. You need a viable business model and customers.

Ideas 106
article thumbnail

How to Gauge Business Potential for Your Invention

Startup Professionals Musings

The honest answer is that ideas and new technologies are worth nothing, outside the context of a specific entrepreneur and a specific business plan that meets a market need for a fair price. File a provisional patent as a place holder, a full patent, trademark, copyright, or all of the above. What is your barrier to entry?

Patents 95